Where does NuVasive, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), NuVasive, Inc. ranks #891 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does NuVasive, Inc. hold?

NuVasive, Inc. holds 504 US utility patents granted between 2015 and 2025, spanning 32 technology areas.

What is NuVasive, Inc.'s Innovation Score?

NuVasive, Inc. has an Innovation Score of 59.9 out of 100 (top 4% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does NuVasive, Inc. focus on?

NuVasive, Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 385 patents. Grants appear in 32 CPC subclasses total.

Is NuVasive, Inc.'s patent grant rate increasing or decreasing?

NuVasive, Inc.'s recent grant velocity is -15% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for NuVasive, Inc.'s patents?

NuVasive, Inc.'s patents average 16.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the NuVasive, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

NuVasive, Inc.

USPTO PatentsView assignee record - 504 granted patents across 32 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Nuvasive ranks #891 of 49,997 tracked US assignees by granted-patent volume, with 504 patents across 32 technology areas.

#891
of 49,997 US assignees by volume: Top 4%
by Innovation Score (59.9/100): 16.1
avg claims per patent: -15%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R891 · US Corporation #891 · 504 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-DOWN · BOOK-FULL

GRANTS-MID 504 grants
TOP-DECILE #891/49,997
PHOTO-FINISH KLA
CPC-FOCUS A61B · 32 areas
INNOV-PAR 59.9/100
CLAIMS-RICH 16.1 claims/avg
TYPE-USCORP US Corporation
VEL-DOWN -15% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: KLA Corporation (±1 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Institute of… · near

60
Jiangnan University · near

60
Know Labs · near

60
NuVasive · this assignee

60
Tohoku University · near

60
3D Lighting… · lowest

7

What this shows Nuvasive's Innovation Score is 59.9/100 (top 4% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Nuvasive's grants concentrate

NuVasive, Inc. is a focused PatentsView assignee: 32 CPC subclasses with 76.4% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2017 (68 grants) versus a trough of 27 in 2020. By volume, Nuvasive sits between Jiangnan University and Nidec Sankyo Corporation.

Nuvasive's three-year grant acceleration

From 2019–2021 to 2022–2024, NuVasive, Inc. moved from 117 to 154 grants (1.32x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #624. See the growth leaderboard.

Jiangnan Universi…

511
Nicoventures Trad…

511
Sumitomo Metal Mi…

511
Entegris

509
Nuvasive ◀

504
KLA

503
Novo Nordisk A/S

503
FEI

502
Nidec Sankyo

502

What this shows NuVasive holds 504 patents at rank #891, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near NuVasive

By rank, the assignees closest to #891 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in NuVasive's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for NuVasive, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (60 here).

Tohoku University 60 Jiangnan University 60 Institute of Geology and Geophysics, Chinese Academy of Sciences 60 Know Labs, Inc. 60

Similar claim depth

Nearest assignees by average claims per patent (16.1 here).

Juul Labs, Inc. 16.1 avg Samsung Electronics Co., Ltd. 16.1 avg Victaulic Company 16.1 avg Rakuten Mobile, Inc. 16.1 avg

Nuvasive's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

60 Top 4% higher than 96% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

NuVasive, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	51	10.1%
2016	43	8.5%
2017	68	13.5%
2018	29	5.8%
2019	59	11.7%
2020	27	5.4%
2021	31	6.2%
2022	44	8.7%
2023	58	11.5%
2024	52	10.3%
2025partial year	42	8.3%

Which technologies does NuVasive, Inc. patent most?

A61B - DIAGNOSIS; SURGERY; Identification 385

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 142

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 44

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 24

G06T - Image Data Processing OR Generation, IN General 22

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 15

G06F - Electric Digital Data Processing 12

B29C - Shaping OR Joining OF PLASTICS; Shaping OF Material IN A Plastic State, NOT Otherwise Provided FOR; After-treatment OF THE Shaped Products, e.g. Repairing 9

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 9

Y10S - Technical Subjects Covered BY Former Uspc Cross-reference ART Collections [XRACs] AND Digests 8

B29L - Indexing Scheme Associated With Subclass B29c, Relating TO Particular Articles 6

H04N - Pictorial Communication, e.g. Television 6

G06N - Computing Arrangements Based ON Specific Computational Models 6

B21D - Working OR Processing OF Sheet Metal OR Metal Tubes, Rods OR Profiles Without Essentially Removing MATERIAL; Punching Metal 5

B21F - Working OR Processing OF Metal Wire 5

Top 15 of 32 technology areas

Where it ranks

Overall rank by patents

#891

of 49,997 tracked assignees

Innovation Score

59.9 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

NuVasive, Inc.'s patent record in context - here's where to go next.

NuVasive, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 76.4% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #891 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare NuVasive, Inc. against Jiangnan University, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 59.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.